Clinical Trial Update: Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pralatrexate with vitamins B12 and folic acid in relapsed or refractory peripheral T-cell lymphoma has completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Pralatrexate (pralatrexate)

Snippet

Sponsor: Acrotech Biopharma Inc. | Conditions: Peripheral T-cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2010-02-01